SCHEMBL6570140

SCHEMBL6570140

CC(C)(C)CC[CH]CCN1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.38
CARM1 Q86X55 1/20 0.34
PRMT6 Q96LA8 1/20 0.34
PRMT8 Q9NR22 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PSMB1 P20618 2/20 0.33
PSMB5 P28074 2/20 0.33
PSMB2 P49721 2/20 0.33
LMNA P02545 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
OPRM1 P35372 1/20 0.33
KCNH2 Q12809 1/20 0.33
CYP1A2 P05177 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11179141 0.82 HRH3 (0.52) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL5489927 0.82 HRH3 (0.52) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL10846103 0.80 HRH3 (0.48) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL24277911 0.78 HRH3 (0.48) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL10032106 0.78 HRH3 (0.48) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL820814 0.78 HRH3 (0.48) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL27879440 0.77 HRH3 (0.42) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL179355 0.75 CARM1 (0.44) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL15658696 0.74 HRH3 (0.44) HRH3CARM1PRMT6PRMT8SIGMAR1
SCHEMBL11889486 0.74 HRH3 (0.56) HRH3SIGMAR1CYP1A2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100503-B1 NON-IMIDAZOLE ALKYLAMINES AS HISTAMINE H 3?-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ILE BIOPROJET SOC CIV (FR) 2004-09-22 EP claimed